Naito, A.; Nagatomo, Y.; Kawai, A.; Yukino-Iwashita, M.; Nakazawa, R.; Taruoka, A.; Takefuji, A.; Yasuda, R.; Toya, T.; Ikegami, Y.;
et al. The Safety and Efficacy of Sodium-Glucose Cotransporter-2 Inhibitors for Patients with Sarcopenia or Frailty: Double Edged Sword? J. Pers. Med. 2024, 14, 141.
https://doi.org/10.3390/jpm14020141
AMA Style
Naito A, Nagatomo Y, Kawai A, Yukino-Iwashita M, Nakazawa R, Taruoka A, Takefuji A, Yasuda R, Toya T, Ikegami Y,
et al. The Safety and Efficacy of Sodium-Glucose Cotransporter-2 Inhibitors for Patients with Sarcopenia or Frailty: Double Edged Sword? Journal of Personalized Medicine. 2024; 14(2):141.
https://doi.org/10.3390/jpm14020141
Chicago/Turabian Style
Naito, Ayami, Yuji Nagatomo, Akane Kawai, Midori Yukino-Iwashita, Ryota Nakazawa, Akira Taruoka, Asako Takefuji, Risako Yasuda, Takumi Toya, Yukinori Ikegami,
and et al. 2024. "The Safety and Efficacy of Sodium-Glucose Cotransporter-2 Inhibitors for Patients with Sarcopenia or Frailty: Double Edged Sword?" Journal of Personalized Medicine 14, no. 2: 141.
https://doi.org/10.3390/jpm14020141
APA Style
Naito, A., Nagatomo, Y., Kawai, A., Yukino-Iwashita, M., Nakazawa, R., Taruoka, A., Takefuji, A., Yasuda, R., Toya, T., Ikegami, Y., Masaki, N., Ido, Y., & Adachi, T.
(2024). The Safety and Efficacy of Sodium-Glucose Cotransporter-2 Inhibitors for Patients with Sarcopenia or Frailty: Double Edged Sword? Journal of Personalized Medicine, 14(2), 141.
https://doi.org/10.3390/jpm14020141